Man Group’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.59M | Buy |
+177,924
| New | +$1.42M | ﹤0.01% | 1664 |
|
|
2025
Q4 | – | Sell |
-70,477
| Closed | -$402K | – | 2490 |
|
|
2025
Q3 | $402K | Sell |
70,477
-186,441
| -73% | -$953K | ﹤0.01% | 1917 |
|
|
2025
Q2 | $1.29M | Buy |
256,918
+164,727
| +179% | +$883K | ﹤0.01% | 1555 |
|
|
2025
Q1 | $597K | Buy |
+92,191
| New | +$820K | ﹤0.01% | 1736 |
|
|
2023
Q4 | – | Hold |
0
| – | -$127K | – | 2272 |
|
|
2023
Q3 | – | Sell |
-297,527
| Closed | -$4.24M | – | 1816 |
|
|
2023
Q2 | $7.3M | Buy |
+297,527
| New | +$7.47M | 0.02% | 740 |
|
|
2023
Q1 | – | Sell |
-67,344
| Closed | -$1.72M | – | 643 |
|
|
2022
Q4 | $1.7M | Sell |
67,344
-93,895
| -58% | -$2.3M | 0.01% | 1160 |
|
|
2022
Q3 | $3.11M | Buy |
+161,239
| New | +$4.1M | 0.01% | 917 |
|
|
2022
Q2 | – | Sell |
-166,391
| Closed | -$3.88M | – | 574 |
|
|
2022
Q1 | $4.28M | Buy |
166,391
+109,637
| +193% | +$3.25M | 0.02% | 947 |
|
|
2021
Q4 | $2.38M | Buy |
56,754
+43,522
| +329% | +$1.71M | 0.01% | 1130 |
|
|
2021
Q3 | $575K | Buy |
13,232
+5,224
| +65% | +$226K | ﹤0.01% | 1497 |
|
|
2021
Q2 | $378K | Buy |
8,008
+695
| +10% | +$31.6K | ﹤0.01% | 1631 |
|
|
2021
Q1 | $375K | Sell |
7,313
-9,818
| -57% | -$529K | ﹤0.01% | 1575 |
|
|
2020
Q4 | $458K | Buy |
+17,131
| New | +$557K | ﹤0.01% | 1575 |
|
|
2020
Q3 | – | Sell |
-39,407
| Closed | -$1.61M | – | 1885 |
|
|
2020
Q2 | $1.61M | Buy |
+39,407
| New | +$1.32M | 0.01% | 1131 |
|
Other funds holding VIR
AVM
SIAU
VPM
GP
VCM
ACM